News
The semiconductor player claims success with D-SaLife in a recent clinical trial involving diabetic outpatients.
The Chicago-based surgical support platform ExplORer Surgical announced today it has closed a funding round worth $2.
The company plans to use the funds to recruit more clients and create a benefits program for its coaches.
GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.
This comes roughly a year after Walgreens pledged to invest $1 billion in equity and convertible debt in VillageMD over a three-year time frame.
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.
Roundup: 'On-the-spot' COVID-19 test receives CE Mark, Thriva launches women's hormones test and mo…
Also, startup creates wearable tech to tackle head injuries in sport.
Using a phone’s camera and flash, the MFine Pulse detects light absorption in a user’s fingertip which is then processed via a proprietary algorithm to measure SpO2.
Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.
The study found that patients using AliveCor Kardia Mobile required fewer follow-up EGCs and cardiac monitoring than their peers in the control group.